Table 2.

Hazard ratios (95% CI) of dysglycemia, diabetes, and prediabetes stratified by ByG index

Exposure	Model 1		Model 2		Model 3
	(HR, 95% CI)	P-value	(HR, 95% CI)	P-value	(HR, 95% CI)	P-value
Dysglycemia
Per SD increment	1.57 (1.36, 1.80)	< 0.001	1.61 (1.40, 1.85)	< 0.001	1.56 (1.34, 1.80)	< 0.001
ByG Tertiles
T1	Reference		Reference		Reference
T2	1.70 (1.10, 2.62)	0.017	1.69 (1.09, 2.61)	0.018	1.60 (1.03, 2.49)	0.037
T3	3.32 (2.24, 4.91)	< 0.001	3.49 (2.35, 5.18)	< 0.001	3.20 (2.13, 4.80)	< 0.001
P for trend		< 0.001		< 0.001		< 0.001
Diabetes
Per SD increment	1.65 (1.40, 1.94)	< 0.001	1.68 (1.42, 1.97)	< 0.001	1.64 (1.38, 1.95)	< 0.001
ByG Tertiles
T1	Reference		Reference		Reference
T2	2.16 (1.31, 3.57)	0.003	2.19 (1.32, 3.61)	0.002	2.05 (1.20, 3.48)	0.008
T3	3.70 (2.31, 5.91)	< 0.001	3.77 (2.35, 6.05)	< 0.001	3.38 (2.02, 5.66)	< 0.001
P for trend		< 0.001		< 0.001		< 0.001
Prediabetes
Per SD increment	1.35 (1.02, 1.79)	0.035	1.44 (1.10, 1.89)	0.009	1.39 (1.04, 1.84)	0.024
ByG Tertiles
T1	Reference		Reference		Reference
T2	1.08 (0.48, 2.46)	0.852	1.13 (0.49, 2.56)	0.778	1.11 (0.48, 2.59)	0.801
T3	2.66 (1.33, 5.34)	0.006	3.06 (1.51, 6.20)	0.002	2.95 (1.44, 6.06)	0.003
P for trend		0.003		< 0.001		0.002

Model 1: adjusted for age, sex and ethnicity. Model 2: adjusted for variables in model 1 plus drinking status, baseline CHD, baseline stroke, smoking status, DBP, and SBP. Model 3: adjusted for variables in model 2 plus ALT, eGFR, TG, HDL-C, ACEIs/ARBs, β-blockers, CCBs, diuretics, statins, AHI, nadir SaO₂, mean SaO₂, and regular CPAP treatment

HR, hazard ratio; CI, confidence interval. Other abbreviations appear in Table 2